de Heer Iris I - OmicsDI

Show results for

Genomics (4)
Metabolomics (1)

Organisms

Homo sapiens (4)

Repository

EGA (4)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Flow injection analysis MS - (1)

Publication Date

2021 (1)

CHEBI ID

CHEBI:173239 (1)
CHEBI:173237 (1)
CHEBI:173234 (1)
CHEBI:173233 (1)
CHEBI:173232 (1)
CHEBI:173231 (1)
CHEBI:173229 (1)
CHEBI:95190 (1)
CHEBI:94807 (1)
CHEBI:89816 (1)
CHEBI:89765 (1)
CHEBI:89754 (1)
CHEBI:89549 (1)
CHEBI:89530 (1)
CHEBI:88740 (1)
CHEBI:88600 (1)
CHEBI:88421 (1)
CHEBI:86909 (1)
CHEBI:86197 (1)
CHEBI:82925 (1)
CHEBI:82124 (1)
CHEBI:80512 (1)
CHEBI:80456 (1)
CHEBI:78862 (1)
CHEBI:75829 (1)
CHEBI:75643 (1)
CHEBI:68967 (1)
CHEBI:6805 (1)
CHEBI:6746 (1)
CHEBI:65370 (1)

Metabolite Name

TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6] (1)
Cyanidin 3-O-[b-D-Xylopyranosyl-(1->2)-[(4-hydroxybenzoyl)-(->6)-b-D-glucopyranoside] (1)
1alpha,3beta,22R-Trihydroxyergosta-5,24E-Dien-26-OicAcid3-O-B-D-Glucoside26-O-B-D-Glucosyl Ester (1)
DG(15:0/18:0/0:0) (1)
(7'x,8'x)-4,7'-Epoxy-3,8'-bilign-7-ene-3,5'-dimethoxy-4',9,9'-triol,3-(4-hydroxyphenyl)-1-[2,4,6-trihydroxy-3-(4-hydroxy-3-methylbut-2-en-1-yl)phenyl]propan-1-one (1)
C29:3 (1)
(2S,4R,6S)-2-[2-(4-Hydroxy-3-methoxyphenyl)ethyl]tetrahydro-6-(4-hydroxy-3,5-dimethoxyphenyl)-2H-pyran-4-ol (1)
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol (1)
C24:3 (1)
Acetylglucosamine sulfate (1)
2-({2-[Dimethyl(2-phosphanylethyl)ammonio]ethyl}dimethylammonio)ethyl phosphinite (1)
Acetyl-Glu-semialdehyde (1)
2-Amino-3-carboxymuconic acid semialdehyde (1)
Silver sulfadiazine (1)
TG(16:0/18:1(9Z)/18:2(9Z,12Z))[iso6] (1)
TG(16:0/16:1(9Z)/18:2(9Z,12Z))[iso6] (1)
TG(16:0/16:1(9Z)/16:1(9Z))[iso3] (1)
TG(16:0/18:0/18:2(9Z,12Z))[iso6] (1)
TG(16:0/16:0/18:0)[iso3] (1)
5-(3',4',5'-trihydroxyphenyl)-gamma-valerolactone-O-methyl-4'-O-glucuronide (1)
PA(16:0/18:1(11Z)) (1)
3,4-DHPEA-EA (1)
N-[(3a,5b,7b)-7-hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]-Glycine (1)
Aldosterone 18-glucuronide (1)
Estriol 3-sulfate 16-glucuronide (1)
PI(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (1)
16b-Hydroxyestrone (1)
Dibenzyl ether (1)
Glucosylceramide (d18:1/26:1(17Z)) (1)
Prebetanin (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Integration of metabolomics, genomics and immune phenotypes reveals the causal roles of metabolites in disease

BACKGROUND: Recent studies highlight the role of metabolites in immune diseases, but it remains unknown how much of this effect is driven by genetic and non-genetic host factors.

RESULT: We systematically investigate circulating metabolites in a cohort of 5...

2021-06-14 | MTBLS2633 | MetaboLights

ena-DATASET-ErasmusMC-30-07-2021-14:00:05:691-768 - samples

Intellance-2: TruSight Tumor 170 panel based DNA-seq

EGAD00001007945 | EGA

ena-DATASET-ErasmusMC-30-07-2021-13:54:47:012-763 - samples

Intellance-2: rRNA-minus RNA-seq

EGAD00001007943 | EGA

ena-DATASET-ErasmusMC-30-07-2021-13:58:26:615-766 - samples

Intellance-2: TruSight Tumor 170 panel based RNA-seq

EGAD00001007944 | EGA

Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.

This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (...

EGAS00001005437 | EGA

Previous page
1 / 1
You're on page 1
Next page